Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00223366 · ClinicalTrials.gov registry record
In Vitro Studies on Pharmacological Regulation and Genetic Risk Factors of Peripheral Human Nociceptors
A clinical trial of Pain, sponsored by The University of Texas Health Science Center at San Antonio.
- Completed
- Registry status
- 2,007
- Enrollment target
- 1
- Study location
NCT00223366: Completed study of Pain, sponsored by The University of Texas Health Science Center at San Antonio.
NCT00223366 is a study of Pain that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 2,007 participants, above the 299-participant average among 374 other Pain trials with a reported enrollment target (571% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00223366, a study of Pain, has completed, sponsored by The University of Texas Health Science Center at San Antonio.
- COMPLETED
- Registry status
- 2,007 participants
- Enrollment target
- 1
- Study location
Study Summary
This protocol is for a number of in vitro studies using human surgical biopsies and evaluating the pharmacology and genetics of human nociceptors ("pain detecting") neurons
Primary Outcome
Extracted human teeth are sectioned to obtain the crown dental pulp which is placed in a well plate. The pulp is moved every twenty minutes through proprietary substances for a total of 60 to 120 minutes depending on the specific experiment. After each 20 minute fraction, the buffer solution in each well plate is collected, labeled and placed in the -80 freezer along with the pulp sample.
Conditions Studied
Study Locations (1)
Texas
- The University of Texas Health Science Center at San Antonio - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,007 participants |
| Start Date | 2001-10 |
| Est. Completion | 2019-05-19 |
What the finished NCT00223366 record still lists
NCT00223366 is an observational study that tracks outcomes without assigning an intervention. Its 2,007 participants enrollment target places it among the larger protocols in the corpus, above the 299-participant average among 374 other Pain trials with a reported enrollment target (571% higher).
The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 0 interventions.
NCT00223366 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00223366 about?
NCT00223366 is a clinical study titled "In Vitro Studies on Pharmacological Regulation and Genetic Risk Factors of Peripheral Human Nociceptors". This protocol is for a number of in vitro studies using human surgical biopsies and evaluating the pharmacology and genetics of human nociceptors ("pain detecting") neurons
What is the current status of trial NCT00223366?
This trial is currently completed. The enrollment target is 2,007 participants. The study started on 2001-10. Estimated completion is 2019-05-19.
What conditions does trial NCT00223366 study?
This clinical trial studies the following conditions: Pain.
Who is sponsoring clinical trial NCT00223366?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00223366 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00223366's enrollment target sits among peer trials
2,007 7th of 374 higher than 368 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Postoperative Pain After Activation of Irrigant
RECRUITING · NA
-
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)
RECRUITING · NA
-
Reliability of Pupil Response to Acute Pain
RECRUITING
-
Pain With Dementia
RECRUITING · NA
-
Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism
RECRUITING · Phase 2
-
Defense and Veterans Center for Integrative Pain Management (DVCIPM) Pain Registry Biobank
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04100564 · 2,009 participants · NA
LITES Task Order 0005 Prehospital Airway Control Trial (PACT)
- NCT04604509 · 2,010 participants · Phase 4
Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I Trial
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia